Adriana Jenkins, a longtime biotech PR professional, died last week from breast cancer. She was 41.
Jenkins, most recently a partner for The Yates Network, also served as senior manager of corporate communications at Millennium Pharmaceuticals, VP at Regan Communications Group, and public affairs manager at Children's Hospital Boston during her career.
"Her fight against breast cancer was chronicled by the Boston Globe in a 2002 special report. Just as she was embarking on an exciting new job at Cambridge, MA-based Millennium Pharmaceuticals in her early 30s, Jenkins learned she had an aggressive form of breast cancer. At the time, she wasn't sure she should accept the job, given that she might die soon."
When Jenkins found out the cancer had returned, giving her weeks to live, she submitted a piece to Forbes that calls for changes in the way that drugs are approved. She wrote about how Herceptin, a drug developed by Genentech and one of the first personalized medicines to be approved, kept her alive for nine years after she was originally diagnosed with breast cancer.
She died February 9.